Phenominer Database Results (71 hits)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
SS.BN-(D6Rat149-D6Arb3)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.77 null 0.64 2.39 necropsy 0 DMBA oral gavage 105 days necropsy 65571 86
WF.WKY-(D7Rat51-D7Rat128)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 23 8.0 null 0.85 4.1 in vivo visual assessment 0 DMBA oral gavage 105 days 66062 654
WF.WKY-(D7Uwm25-D7Rat128)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 43 7.2 null 0.46 3.0 in vivo visual assessment 0 DMBA oral gavage 105 days 66063 654
SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 25 9.24 null 0.65 3.25 manual palpation method 0 DMBA oral gavage 133 days 11357 74
ACI.COP-(D6Rat80-D6Rat146)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11359 75
ACI.COP-(D3Rat130-D3Rat114)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11363 75
ACI.COP-(D10Mgh8-D10Rat4)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 12 4.8 null 1.04 3.6 necropsy 0 11366 75
WF.WKY-(D5Rat26-D5Uwm42)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60 mammary gland integrity trait female 155 days-160 days 29 5.7 null 0.6 3.23 unspecified method 0 3X3 mm diameter or larger 11745 142
WF.WKY-(D5Uwm77-D5Uwm91)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 12 3.8 null 0.8 2.77 in vivo visual assessment 0.0 0 70313 653
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 46 7.9 null 0.5 3.39 in vivo visual assessment 0.0 0 70314 653
WF.WKY-(D5Uwm67-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 35 3.2 null 0.4 2.37 in vivo visual assessment 0.0 0 70296 653
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 29 6.3 null 0.5 2.69 necropsy 0.0 0 3X3 mm diameter or larger 70167 143
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 46 7.61 null 0.45 3.05 manual palpation method 0 DMBA oral gavage 133 days 11356 74
WKY/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Lan H, et al., Genetics 2001 Jan;157(1):331-9 mammary gland integrity trait female 169 days-174 days 17 0.0 null necropsy 0 3X3 mm diameter or larger 11741 141
WF mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 19 7.3 null 0.83 3.6 in vivo visual assessment 0 DMBA oral gavage 105 days 66067 654
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 17 10.89 null 0.43 1.77 manual palpation method 0 DMBA oral gavage 133 days 11354 74
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 21 7.0 null 1.16 5.3 necropsy 0 11368 75
COP/CrCrl mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 7 0.1 null 0.15 0.4 necropsy 0 11370 75
BN/SsNHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 196 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 259 days 13 0.0 null manual palpation method crystalline implant 0 11381 81
SS-Chr 13BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 5.33 null 1.21 4.38 necropsy 0 DMBA oral gavage 105 days necropsy 11501 86
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 34 3.82 null 0.43 2.51 manual palpation method 0.0 0 76265 1558
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 48 11.23 null 0.07 0.51 necropsy 0 DMBA oral gavage 0 necropsy 11340 73
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 14 3.93 null 0.17 0.64 necropsy 0 DMBA oral gavage 0 necropsy 11341 73
SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 33 5.0 null 0.44 2.53 manual palpation method 0 DMBA oral gavage 133 days 11358 74
ACI.COP-(D3Mgh16-D3Rat119)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 8 4.3 null 1.13 3.2 necropsy 0 11362 75
ACI.COP-(D10Mgh8-D10Rat4)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11365 75
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 99 and 197 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 mammary gland integrity trait female 160 days-260 days 20 5.6 null necropsy 0.0 0 tumor size reach 1-1.5 cm 11377 76
WF.WKY-(D7Rat171-D7Rat128)/1Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 17 3.5 null 0.61 2.5 in vivo visual assessment 0 DMBA oral gavage 105 days 66060 654
WF.WKY-(D7Rat171-D7Rat128)/2Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 32 3.9 null 0.46 2.6 in vivo visual assessment 0 DMBA oral gavage 105 days 66061 654
WF.COP-(D7Rat39-D7Uwm12)/2Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 16 2.0 null 0.38 1.5 in vivo visual assessment 0 DMBA oral gavage 105 days 66066 654
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 143 days-259 days 22 8.8 null 1.4 6.57 manual palpation method 0.0 crystalline implant 0 11382 81
SS-Chr 16BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 6.31 null 1.61 5.79 necropsy 0 DMBA oral gavage 105 days necropsy 11504 86
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Lan H, et al., Genetics 2001 Jan;157(1):331-9 mammary gland integrity trait female 169 days-174 days 21 7.3 null 0.98 4.5 necropsy 0 3X3 mm diameter or larger 11742 141
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60 mammary gland integrity trait female 155 days-160 days 50 6.9 null 0.4 2.83 unspecified method 0 3X3 mm diameter or larger 11743 142
COP/OlaHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 16 0.25 null 0.1 0.4 necropsy 0 3X3 mm diameter or larger 11747 143
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 144 and 195 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 203 days-264 days 34 3.9 null 0.6 3.5 manual palpation method 0 0 11752 144
WF.WKY-(D5Uwm67-D5Uwm81)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 26 8.3 null 0.7 3.57 in vivo visual assessment 0.0 0 70303 653
WF.WKY-(D5Uwm76-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 4.8 null 0.4 3.05 in vivo visual assessment 0.0 0 70304 653
WF.WKY-(D5Uwm78-D5Uwm84)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 41 8.1 null 0.6 3.84 in vivo visual assessment 0.0 0 70307 653
WF.COP-(D2Mit29-D2Rat201)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 19 1.5 null 0.3 1.31 necropsy 0.0 0 3X3 mm diameter or larger 70168 143
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 32 2.84 null 0.31 1.75 manual palpation method 0.0 0 76264 1558
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 24 5.0 null 0.88 4.31 manual palpation method 0.0 0 76266 1558
WF.WKY-(D7Rat171-D7Rat45)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 28 3.4 null 0.4 2.1 in vivo visual assessment 0 DMBA oral gavage 105 days 66064 654
SS-Chr 19BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 8.79 null 1.25 4.68 necropsy 0 DMBA oral gavage 105 days necropsy 11507 86
ACI.COP-(D6Rat80-D6Rat146)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 17 2.4 null 0.41 1.7 necropsy 0 11360 75
ACI/SegHsd mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 4 0.0 null necropsy 0 11367 75
COP/CrCrl mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 5 0.0 null necropsy 0 11369 75
WF.WKY-(D5Wox7-D5Uwm37)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60 mammary gland integrity trait female 155 days-160 days 13 1.1 null 0.3 1.08 unspecified method 0 3X3 mm diameter or larger 11744 142
WF.WKY-(D5Uwm76-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 26 3.8 null 0.4 2.04 in vivo visual assessment 0.0 0 70298 653
WF.WKY-(D5Uwm78-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 32 2.8 null 0.3 1.7 in vivo visual assessment 0.0 0 70301 653
WF.WKY-(D5Uwm95-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 36 7.4 null 0.6 3.6 in vivo visual assessment 0.0 0 70302 653
WF.WKY-(D5Uwm78-D5Uwm84)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 29 8.8 null 0.7 3.77 in vivo visual assessment 0.0 0 70305 653
WF.WKY-(D5Uwm78-D5Uwm93)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 27 5.0 null 0.5 2.6 in vivo visual assessment 0.0 0 70306 653
WF.WKY-(D5Uwm88-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 6.9 null 0.6 4.57 in vivo visual assessment 0.0 0 70308 653
WF.WKY-(D5Uwm87-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 56 6.3 null 0.4 2.99 in vivo visual assessment 0.0 0 70309 653
WF.WKY-(D5Uwm85-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 51 3.9 null 0.3 2.14 in vivo visual assessment 0.0 0 70310 653
WF.WKY-(D5Uwm82-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 18 2.6 null 0.6 2.55 in vivo visual assessment 0.0 0 70311 653
WF.WKY-(D5Uwm82-D5Uwm91)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 3.4 null 0.3 2.28 in vivo visual assessment 0.0 0 70312 653
WF.COP-(D7Rat39-D7Uwm12)/1Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Sanders J, et al., PLoS One. 2011;6(5):e19891. Epub 2011 May 18. mammary gland integrity trait female 155 days-160 days 16 2.4 null 0.4 1.6 in vivo visual assessment 0 DMBA oral gavage 105 days 66065 654
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 46 7.61 null 0.07 0.45 necropsy 0 DMBA oral gavage 0 necropsy 11342 73
ACI.COP-(D3Mgh16-D3Rat119)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11361 75
ACI.COP-(D3Rat130-D3Rat114)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 17 4.5 null 0.73 3.0 necropsy 0 11364 75
SS/JrHsdMcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 2.45 null 0.21 1.32 necropsy 0 DMBA oral gavage 105 days necropsy 11488 86
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.86 null 0.7 2.63 necropsy 0 DMBA oral gavage 105 days necropsy 65573 86
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 14 3.93 null 0.64 2.39 manual palpation method 0 DMBA oral gavage 133 days 11355 74
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 30 8.1 null 0.7 3.83 necropsy 0 3X3 mm diameter or larger 11746 143
COP/OlaHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 212 and 330 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 271 days-397 days 20 0.4 null 0.13 0.6 manual palpation method 0 0 11753 144
WF mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days) Shepel LA, et al., Genetics 1998 May;149(1):289-99 mammary gland integrity trait female 181 days-200 days 53 3.62 null 0.27 1.95 necropsy 0.0 DMBA oral gavage 126 days from 126 to 140 days 66100 689
WF.WKY-(D5Uwm76-D5Uwm61)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 40 4.2 null 0.4 2.53 in vivo visual assessment 0.0 0 70297 653
WF.WKY-(D5Uwm67-D5Uwm78)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 32 8.6 null 0.8 4.53 in vivo visual assessment 0.0 0 70299 653
WF.WKY-(D5Uwm76-D5Got18)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 27 3.5 null 0.4 2.08 in vivo visual assessment 0.0 0 70300 653